Gestational diabetes mellitus (GDM) poses significant risks to both mother and fetus. As healthcare professionals, it's imperative to stay informed about the latest strategies for effective management.
Early detection of GDM is crucial. The American Diabetes Association recommends universal screening between 24-28 weeks gestation using the 75g oral glucose tolerance test.
Initial management should involve lifestyle modification, including dietary changes and exercise. If blood glucose targets are not achieved, pharmacological treatment may be necessary. Insulin remains the first-line therapy, but oral hypoglycemic agents are gaining acceptance.
Postpartum follow-up is essential as women with GDM have a seven-fold increased risk of developing type 2 diabetes. Regular screening and lifestyle interventions can mitigate this risk.
Optimal management of GDM requires early detection, appropriate intervention, and vigilant follow-up. By staying updated with the latest guidelines, we can ensure the best possible outcomes for our patients.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation